CHAR Technologies (TSXV:YES) Announces Fiscal Year 2025 Results

TORONTO, ON — January 28, 2026 — Leads & Copy — CHAR Technologies Ltd. (TSXV:YES)(FSE:68K) has released its financial results for the fiscal year ended September 30th, 2025. The company is a leader in sustainable biomass energy solutions for heavy industry decarbonization.

According to Andrew White, CEO of CHAR Technologies, the company is proud of the progress made this year as it transitioned its Thorold project from a successful pilot into commercialization with a limited partnership structure. This transition led to significant changes in the company’s corporate consolidated financials, including a gain on contribution to joint venture of just over $4 million and a reduction in liabilities of just under $11 million.

Management highlighted key milestones in the fiscal year ended September 30th, 2025:

  • Partnership with the BMI Group (“BMI”), which saw BMI invest $2 million into CHAR Tech, and $C8 million into the Thorold Project during the fiscal year. Subsequent to fiscal year end, BMI committed $10 million to the Espanola Biocarbon project, as press released January 14th, 2026.
  • Commercial biocarbon production from the Thorold facility. Production is set to increase as the Thorold project moves through construction and commissioning.
  • Deployment of a high temperature pyrolysis system in Baltimore with the City of Baltimore and Synagro for the destruction of PFAS in biosolids, which CHAR Technologies says is the first known deployment of high temperature pyrolysis for the destruction of PFAS globally. This HTP installation is also cleaning produced pyrolysis gas, creating syngas for energy uses, which the company says is another global first in the pyrolysis of biosolids.

Financial highlights for the fiscal year ended September 30th, 2025:

  • Total assets decreased by $6,465,625 (from $15,352,471 to $8,886,846).
  • Total liabilities decreased by $10,892,692 (from $14,880,781 to $3,988,089).
  • Total shareholders’ equity increased by $4,427,067 (from $471,690 to $4,898,757).
  • Total revenue of $2,195,650 (compared to $3,161,996).
  • Gross profit of $850,414 (compared to $631,582).
  • Gain on contribution to joint venture of $4,131,709 (compared to $nil).
  • Net loss before income taxes of ($1,121,188) (compared to ($7,524,006)).

Subsequent Events:

On December 22, 2025, the Company completed a non-brokered private placement, issuing 4,550,000 units at a price of $0.22 per unit for gross proceeds of $1,001,000. Each unit consists of one common share and one non-transferable common share purchase warrant, with each whole warrant exercisable at $0.32 per share for a period of 24 months from the closing date. The Company incurred finder’s fees of approximately $60,000 in connection with the offering.

On December 31, 2025, CHAR Technologies Ltd. announced its common shares were listed on the Frankfurt Stock Exchange under ticker symbol “68K”.

The biosolids PFAS destruction demonstration project in Baltimore completed its six-month operational program and was fully operating as of November 6, 2025. Performance data generated during the demonstration is currently being compiled and analyzed.

On January 14, 2026, CHAR Technologies Ltd. announced that the engineering and design study for the Espanola biocarbon project continues to advance with The BMI Group. BMI reaffirmed its commitment of approximately $10 million toward the project.

On January 21st, 2026 the High Court of Justice in the United Kingdom found in favour of Actinon in respect of its summary judgement application against the Company’s subsidiary CHAR Biocarbon Inc. The sum of US$635,810 is now payable by CHAR Biocarbon Inc. to Actinon.

CHAR Tech develops high-temperature pyrolysis systems that process wood and organic waste to generate renewable natural gas or green hydrogen, and a solid biocarbon that serves as a carbon-neutral replacement for metallurgical coal. CHAR Tech’s HTP platform is also focused on the destruction of PFAS in wastewater biosolids.

Source: CHAR Technologies Ltd.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.